163 related articles for article (PubMed ID: 22215245)
1. Differences of the lymphatic distribution and surgical outcomes between remnant gastric cancers and primary proximal gastric cancers.
Komatsu S; Ichikawa D; Okamoto K; Ikoma D; Tsujiura M; Shiozaki A; Fujiwara H; Murayama Y; Kuriu Y; Ikoma H; Nakanishi M; Ochiai T; Kokuba Y; Otsuji E
J Gastrointest Surg; 2012 Mar; 16(3):503-8. PubMed ID: 22215245
[TBL] [Abstract][Full Text] [Related]
2. Progression of remnant gastric cancer is associated with duration of follow-up following distal gastrectomy.
Komatsu S; Ichikawa D; Okamoto K; Ikoma D; Tsujiura M; Nishimura Y; Murayama Y; Shiozaki A; Ikoma H; Kuriu Y; Nakanishi M; Fujiwara H; Ochiai T; Kokuba Y; Otsuji E
World J Gastroenterol; 2012 Jun; 18(22):2832-6. PubMed ID: 22719193
[TBL] [Abstract][Full Text] [Related]
3. Optimal extent of lymph node dissection for remnant advanced gastric carcinoma after distal gastrectomy: a retrospective analysis of more than 3000 patients from the nationwide registry of the Japanese Gastric Cancer Association.
Katai H; Ishikawa T; Akazawa K; Fukagawa T; Isobe Y; Miyashiro I; Oda I; Tsujitani S; Ono H; Tanabe S; Nunobe S; Suzuki S; Kakeji Y;
Gastric Cancer; 2020 Nov; 23(6):1091-1101. PubMed ID: 32419120
[TBL] [Abstract][Full Text] [Related]
4. Gastric stump cancer after distal gastrectomy for benign disease: clinicopathological features and surgical outcomes.
Di Leo A; Pedrazzani C; Bencivenga M; Coniglio A; Rosa F; Morgani P; Marrelli D; Marchet A; Cozzaglio L; Giacopuzzi S; Tiberio GA; Doglietto GB; Vittimberga G; Roviello F; Ricci F
Ann Surg Oncol; 2014 Aug; 21(8):2594-600. PubMed ID: 24639193
[TBL] [Abstract][Full Text] [Related]
5. Lymph node dissection in surgical treatment for remnant stomach cancer.
Kunisaki C; Shimada H; Nomura M; Hosaka N; Akiyama H; Ookubo K; Moriwaki Y; Yamaoka H
Hepatogastroenterology; 2002; 49(44):580-4. PubMed ID: 11995502
[TBL] [Abstract][Full Text] [Related]
6. [Study on the clinicopathologic characteristics and prognostic difference of gastric stump cancer between non-anastomotic site and anastomotic site].
Chen L; Wei S; Ye Z; Wang Y; Zheng Q; Zhuo C; Xiao J; Zeng Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jan; 20(1):67-72. PubMed ID: 28105623
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Optimal Lymph Node Dissection in Remnant Gastric Cancer Based on Initial Distal Gastrectomy.
Iguchi K; Kunisaki C; Sato S; Tanaka Y; Miyamoto H; Kosaka T; Akiyama H; Endo I; Rino Y; Masuda M
Anticancer Res; 2018 Mar; 38(3):1677-1683. PubMed ID: 29491102
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic features of remnant gastric cancer after curative distal gastrectomy according to previous reconstruction method: a retrospective cohort study.
Park YE; Kim SW
World J Surg Oncol; 2019 Nov; 17(1):203. PubMed ID: 31785616
[TBL] [Abstract][Full Text] [Related]
9. "Five-step" laparoscopic lymph node dissection for remnant gastric cancer following Billroth-II gastrectomy: A safe and feasible procedure.
Zheng ZF; Lu J; Zheng CH; Huang CM
Surg Oncol; 2020 Mar; 32():115-116. PubMed ID: 31874429
[TBL] [Abstract][Full Text] [Related]
10. Short- and Long-term Outcomes of Surgical Treatment for Remnant Gastric Cancer After Distal Gastrectomy.
Nakaji YU; Saeki H; Kudou K; Nakanishi R; Sugiyama M; Nakashima Y; Ando K; Oda Y; Oki E; Maehara Y
Anticancer Res; 2019 Mar; 39(3):1411-1415. PubMed ID: 30842176
[TBL] [Abstract][Full Text] [Related]
11. The value of N staging with the positive lymph node ratio, and splenectomy, for remnant gastric cancer: A multicenter retrospective study.
Son SY; Kong SH; Ahn HS; Park YS; Ahn SH; Suh YS; Park DJ; Lee HJ; Kim HH; Yang HK
J Surg Oncol; 2017 Dec; 116(7):884-893. PubMed ID: 28650587
[TBL] [Abstract][Full Text] [Related]
12. [Risk factor analysis and prediction model establishment of lymph node metastasis in remnant gastric cancer].
Wang W; Nie R; Zhou Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 May; 21(5):541-545. PubMed ID: 29774936
[TBL] [Abstract][Full Text] [Related]
13. Surgical Resection of Remnant Gastric Cancer Following Distal Gastrectomy: A Retrospective Clinicopathological Study.
Takahashi M; Takeuchi H; Tsuwano S; Nakamura R; Takahashi T; Wada N; Kawakubo H; Saikawa Y; Kitagawa Y
Ann Surg Oncol; 2016 Feb; 23(2):511-21. PubMed ID: 26104543
[TBL] [Abstract][Full Text] [Related]
14. Risk evaluation of splenic hilar or splenic artery lymph node metastasis and survival analysis for patients with proximal gastric cancer after curative gastrectomy: a retrospective study.
Ding P; Gao Z; Zheng C; Chen J; Li K; Gao S
BMC Cancer; 2019 Sep; 19(1):905. PubMed ID: 31510966
[TBL] [Abstract][Full Text] [Related]
15. Does remnant gastric cancer really differ from primary gastric cancer? A systematic review of the literature by the Task Force of Japanese Gastric Cancer Association.
Shimada H; Fukagawa T; Haga Y; Oba K
Gastric Cancer; 2016 Apr; 19(2):339-349. PubMed ID: 26667370
[TBL] [Abstract][Full Text] [Related]
16. Staging for Remnant Gastric Cancer: The Metastatic Lymph Node Ratio vs. the UICC 7th Edition System.
Nakagawa M; Choi YY; An JY; Hong JH; Kim JW; Kim HI; Cheong JH; Hyung WJ; Choi SH; Noh SH
Ann Surg Oncol; 2016 Dec; 23(13):4322-4331. PubMed ID: 27370654
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of clinicopathological features and prognosis analysis between gastric stump cancer and recurrence of gastric cancer after radical gastrectomy].
Xi H; Li J; Li S; Qiao Z; Wei B; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 May; 21(5):507-513. PubMed ID: 29774931
[TBL] [Abstract][Full Text] [Related]
18. Surgical results of remnant gastric cancer treatment.
Ramos MFKP; Pereira MCM; Oliveira YS; Pereira MA; Barchi LC; Dias AR; Zilberstein B; Ribeiro Junior U; Cecconello I
Rev Col Bras Cir; 2020; 47():e20202703. PubMed ID: 33263654
[TBL] [Abstract][Full Text] [Related]
19. Gastric remnant cancer patients had a better prognosis than upper-third gastric cancer patients in a case-control study after surgical treatment.
Li F; Zhang R; Liang H; Quan J; Liu H; Zhang H
Tumori; 2013; 99(4):510-5. PubMed ID: 24326840
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the optimal treatment strategy for early and advanced remnant gastric cancer.
Hayashi M; Fujita T; Matsushita H
ANZ J Surg; 2022 Nov; 92(11):2907-2914. PubMed ID: 36117449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
